These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report). Mihál V, Hajdúch M, Dusek J, Jarosová M, Weigl E, Pikalová Z, Indrák K, Safárová M, Janostáková A. Neoplasma; 1997 Aug; 44(2):133-6. PubMed ID: 9201294 [Abstract] [Full Text] [Related]
8. Acute lymphoblastic leukemia with the phenotype of a putative B-cell/T-cell bipotential precursor. Lau LG, Tan LK, Koay ES, Ee MH, Tan SH, Liu TC. Am J Hematol; 2004 Oct; 77(2):156-60. PubMed ID: 15389907 [Abstract] [Full Text] [Related]
9. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia. Han Y, Xue Y, Zhang J, Wu Y, Pan J, Wang Y, Shen J, Dai H, Bai S. Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493 [Abstract] [Full Text] [Related]
11. Molecular detection of minimal residual disease is associated with early relapse in adult acute lymphoblastic leukemia. Specchia G, Liso A, Pannunzio A, Albano F, Mestice A, Pastore D, Liso V. Haematologica; 2004 Oct; 89(10):1271-3. PubMed ID: 15477219 [Abstract] [Full Text] [Related]
12. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group. Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, Lakomek M, Henze G, von Stackelberg A. J Clin Oncol; 2009 Jul 10; 27(20):3363-9. PubMed ID: 19433688 [Abstract] [Full Text] [Related]
13. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia. Nishida H, Yoshimizu N, Ueno H, Fujita A, Kato T, Park JW, Yano T, Tobinai K, Ikeda Y. Leuk Res; 2007 Mar 10; 31(3):417-8. PubMed ID: 16730062 [No Abstract] [Full Text] [Related]
14. Precursor T-cell acute lymphoblastic leukemia in adults: age-related immunophenotypic, cytogenetic, and molecular subsets. Onciu M, Lai R, Vega F, Bueso-Ramos C, Medeiros LJ. Am J Clin Pathol; 2002 Feb 10; 117(2):252-8. PubMed ID: 11863221 [Abstract] [Full Text] [Related]
19. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. Attarbaschi A, Mann G, Panzer-Grümayer R, Röttgers S, Steiner M, König M, Csinady E, Dworzak MN, Seidel M, Janousek D, Möricke A, Reichelt C, Harbott J, Schrappe M, Gadner H, Haas OA. J Clin Oncol; 2008 Jun 20; 26(18):3046-50. PubMed ID: 18565891 [Abstract] [Full Text] [Related]
20. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y. Ai Zheng; 2007 Apr 20; 26(4):418-22. PubMed ID: 17430665 [Abstract] [Full Text] [Related] Page: [Next] [New Search]